Molecular mechanisms of cisplatin resistance in cervical cancer

doi:10.2147/DDDT.S106412

科研成果详情

题名	Molecular mechanisms of cisplatin resistance in cervical cancer
作者	Zhu, Haiyan; Luo, Hui; Zhang, Wenwen; Shen, Zhaojun; Hu, Xiaoli; Zhu, Xueqiong
发表日期	2016-12-31
发表期刊	DRUG DESIGN DEVELOPMENT AND THERAPY 影响因子和分区
语种	英语
原始文献类型	Review
关键词	cisplatin epithelial-mesenchymal transition microRNA molecular mechanism resistance
其他关键词	SQUAMOUS-CELL CARCINOMA ; ENDOPLASMIC-RETICULUM STRESS ; ANTICANCER DRUG CISPLATIN ; GLUTATHIONE-S-TRANSFERASE ; COPPER TRANSPORTER CTR1 ; MORINDA-CITRIFOLIA NONI ; INDUCED APOPTOSIS ; TUMOR-CELLS ; DNA-DAMAGE ; IN-VITRO
摘要	Patients with advanced or recurrent cervical cancer have poor prognosis, and their 1-year survival is only 10%-20%. Chemotherapy is considered as the standard treatment for patients with advanced or recurrent cervical cancer, and cisplatin appears to treat the disease effectively. However, resistance to cisplatin may develop, thus substantially compromising the efficacy of cisplatin to treat advanced or recurrent cervical cancer. In this article, we systematically review the recent literature and summarize the recent advances in our understanding of the molecular mechanisms underlying cisplatin resistance in cervical cancer.
资助项目	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81372381]; medical and technology project of Zhejiang Province [2016KYA141]
出版者	DOVE MEDICAL PRESS LTD
出版地	ALBANY
ISSN	1177-8881
卷号	10 页码:1885-1895
DOI	10.2147/DDDT.S106412
页数	11
WOS类目	Chemistry, Medicinal ; Pharmacology & Pharmacy
WOS研究方向	Pharmacology & Pharmacy
WOS记录号	WOS:000377518700002
收录类别	SCIE ; PUBMED ; SCOPUS
URL	查看原文
PubMed ID	27354763
PMC记录号	PMC4907638
SCOPUSEID	2-s2.0-84973444388
ESI高被引论文	2020-09 ; 2020-11 ; 2021-01 ; 2021-03 ; 2021-05 ; 2021-07 ; 2021-09 ; 2021-11 ; 2022-01 ; 2022-03 ; 2022-05 ; 2022-07 ; 2022-09 ; 2022-11 ; 2023-01 ; 2023-03 ; 2023-05 ; 2023-07 ; 2023-09 ; 2023-11 ; 2024-01 ; 2024-03 ; 2024-05 ; 2024-07 ; 2024-09
通讯作者地址	[Zhu, Xueqiong]Department of Obstetrics and Gynecology,Second Affiliated Hospital of Wenzhou Medical University,No 109, Xueyuan Xi Road,Wenzhou,325027,China
Scopus学科分类	Pharmacology;Pharmaceutical Science;Drug Discovery
引用统计	被引频次：202[WOS] [WOS记录] [WOS相关记录]
文献类型	期刊论文
条目标识符	https://kms.wmu.edu.cn/handle/3ETUA0LF/14213
专题	第二临床医学院，附属第二医院、育英儿童医院附属第二医院
通讯作者	Zhu, Xueqiong
作者单位	Department of Obstetrics and Gynecology,Second Affiliated Hospital of Wenzhou Medical University,Wenzhou,China
第一作者单位	第二临床医学院，附属第二医院、育英儿童医院; 附属第二医院
通讯作者单位	第二临床医学院，附属第二医院、育英儿童医院; 附属第二医院
第一作者的第一单位	第二临床医学院，附属第二医院、育英儿童医院; 附属第二医院
推荐引用方式 GB/T 7714	Zhu, Haiyan,Luo, Hui,Zhang, Wenwen,et al. Molecular mechanisms of cisplatin resistance in cervical cancer[J]. DRUG DESIGN DEVELOPMENT AND THERAPY,2016,10:1885-1895.
APA	Zhu, Haiyan, Luo, Hui, Zhang, Wenwen, Shen, Zhaojun, Hu, Xiaoli, & Zhu, Xueqiong. (2016). Molecular mechanisms of cisplatin resistance in cervical cancer. DRUG DESIGN DEVELOPMENT AND THERAPY, 10, 1885-1895.
MLA	Zhu, Haiyan,et al."Molecular mechanisms of cisplatin resistance in cervical cancer".DRUG DESIGN DEVELOPMENT AND THERAPY 10(2016):1885-1895.